digital PCR

The firm plans to add more oncology tests, NIPTs and newborn screening assays through in-house development and partnerships with third-party assay makers.

The new chip enables the firm's digital PCR system to test up to 240 samples per day, and also uses lower volumes of sample input. 

Roche said at the AMP annual meeting that it plans to commercialize the system in Europe with CE IVD marking for clinical applications and in the US with a 510(k) exemption.

The firm has provided glimpses into its strategies for developing a line of regulated droplet digital PCR tests in a number of recent forums.

The new European initiative promises to deliver multiple new tests and methods for improving the treatment of breast cancer and rectal cancer.